Hodgkin’s lymphoma in a patient on adalimumab treatment for psoriasis

Adalimumab is a human monoclonal antibody which targets tumor necrosis factor (TNF)-alpha. It is produced by recombinant DNA technology, using a mammalian cell expression system and is widely-known to treat a number of immune-mediated conditions, including psoriasis. There has been a growing concern...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:AME Case Rep
Asıl Yazarlar: Alballa, Nouf, Alyousef, Alanoud, Alamari, Albatool, Alhumidi, Ahmed Abdullah, Zayed, Mohammed Ayesh, Zeitouni, Leena, Alsaif, Fahad Mohammed
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2018
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6327155/
https://ncbi.nlm.nih.gov/pubmed/30701218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/acr.2018.12.01
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller